Speakers: Kenneth Miller MD, Tufts Medical Center; Christina Ferraro MSN, CNP,CMTCN, Cleveland Clinic Recorded October 12, 2019 at the National GVHD Patient Summit Presentation 40 minute, Q&A 20 minutes Highlights

Transcript of Presentation: 00:00 Introductions: Welcome, everyone. This is a lightning round and ask the transplant experts. We're going to begin the day with introducing our panelists. We're honored to

Genital graft-versus-host disease (GVHD) can affect both men and women after transplant, making sex painful. Topical steroids and, in some women, estrogen is the usual treatment.

Graft-versus-host disease often affects the gastrointestinal system, and sometimes the liver. Prednisone is usually the first line of treatment. Other medications and therapies are available if prednisone, alone, is not effective.